[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Sharon-Rose Maloney\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":47},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":29,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":4},"100585009",false,"NCT06896786","This Study Evaluates the Impact of the Sodium Management Tool (SMT) on Hemodialysis Patient Outcomes Compared to Standard Care","Sodium Management Tool in Hemodialysis Patients","SOMEDIA","Inclusion Criteria:\n\n* Outpatients on hemodialysis for at least three months,\n* Dialysis three times a week, age \\>\u002F= 18,\n* dialysis with a Fresenius 6008 Machine,\n* signed informed consent\n\nExclusion:\n\n* Dialysis access with repeated Interruption due to flow problems\n* plasma natrium \\\u003C 130 mmol\u002Fl, \\> 145 mmol\u002Fl, pregnancy -","ALL","18 Years",{"count":19,"type":20},30,"ESTIMATED","INTERVENTIONAL",[23],"NA","Title of the Study: Sodium Management Tool in Hemodialysis Patients\n\nBrief Summary:\n\nThe goal of this clinical trial is to learn whether the Sodium Management Tool (SMT) can improve patients clnical outcomes.\n\nThe main questions this study aims to answer are:\n\nDoes the SMT help reduce weight gain between dialysis sessions? Does the SMT improve dialysis tolerance by reducing symptoms like low blood pressure and muscle cramps?\n\nResearchers will compare standard dialysis to dialysis using the SMT to see if clinical outcomes are better in dialysis that use the SMT.\n\nParticipants will:\n\nReceive dialysis three times per week with either standard dialysis or SMT-activated dialysis Switch between standard dialysis and SMT-activated dialysis after 4 weeks Have their blood pressure, sodium levels, and symptoms monitored during treatment Report their symptoms and thirst levels in a questionnaire Some participants may continue for an additional 4 weeks with a personalized SMT setting based on their symptoms and weight changes.\n\nThis study will help determine whether the SMT can improve sodium balance and make dialysis more comfortable for patients.",[26,27,28],"Hemodialysis","Interdialytic Weight Gain","Intradialytic Hypotension",[30,31,32,33,34],"sodium management in hemodialyis patients","management of complaints in hemodialysis patients","interdialytic weight gain","intradialytic hypotension","sodium management tool","NOT_YET_RECRUITING","2025-03-19",{"date":38,"type":39},"2025-03-26","ACTUAL",{"date":41,"type":20},"2025-04-01",{"date":43,"type":20},"2025-08-31",{"name":45,"class":46},"Sharon-Rose Maloney","OTHER",""]